CHRONIC GRAFT VERSUS HOST DISEASE ORAL

CHRONIC GRAFT VERSUS HOST DISEASE ORAL was reported 245 times

CHRONIC GRAFT VERSUS HOST DISEASE ORAL is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Cytomegalovirus DNA Terminase Complex Inhibitor [EPC] 3 0.0009
1 Calcineurin Inhibitor Immunosuppressant [EPC] 92 0.0007
2 CCR5 Co-receptor Antagonist [EPC] 1 0.0004
3 Antimalarial [EPC] 4 0.0004
4 Antiprotozoal [EPC] 4 0.0004
5 CD22-directed Immunoconjugate [EPC] 1 0.0003
6 Janus Kinase Inhibitor [EPC] 45 0.0003
7 Alkylating Drug [EPC] 67 0.0003
8 CD52-directed Cytolytic Antibody [EPC] 5 0.0003
9 Provitamin D2 Compound [EPC] 6 0.0002
10 Bile Acid [EPC] 4 0.0002
11 Folate Analog Metabolic Inhibitor [EPC] 69 0.0002
12 Asparagine-specific Enzyme [EPC] 2 0.0001
13 Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] 3 0.0001
14 Kinase Inhibitor [EPC] 69 0.0001
15 Echinocandin Antifungal [EPC] 1 0.0001
16 Antifibrinolytic Agent [EPC] 1 0.0001
17 Purine Antimetabolite [EPC] 10 0.0001
18 Corticosteroid [EPC] 129 0.0001
19 CD30-directed Immunoconjugate [EPC] 1 0.0001
20 Antimetabolite Immunosuppressant [EPC] 2 0.0001
21 Topoisomerase Inhibitor [EPC] 7 0.0001
22 Azole Antifungal [EPC] 14 0.0001
23 Nucleoside Metabolic Inhibitor [EPC] 22 0.0001
24 CD20-directed Cytolytic Antibody [EPC] 25 0.0001
25 Selective T Cell Costimulation Modulator [EPC] 11 0.0001
26 BCL-2 Inhibitor [EPC] 4 0.0001
27 Nitrofuran Antibacterial [EPC] 1 0.0001
28 Rifamycin Antibacterial [EPC] 2 0.0001
29 Dihydrofolate Reductase Inhibitor Antibacterial [EPC] 5 0.0001
30 Human Immunoglobulin G [EPC] 1 0.0000
31 Integrin Receptor Antagonist [EPC] 4 0.0000
32 Glycopeptide Antibacterial [EPC] 3 0.0000
33 Thalidomide Analog [EPC] 19 0.0000
34 Leukotriene Receptor Antagonist [EPC] 1 0.0000
35 Leukocyte Growth Factor [EPC] 4 0.0000
36 Proteasome Inhibitor [EPC] 3 0.0000
37 Nucleoside Analog Antiviral [EPC] 2 0.0000
38 Fluoroquinolone Antibacterial [EPC] 3 0.0000
39 gamma-Aminobutyric Acid-ergic Agonist [EPC] 2 0.0000
40 CTLA-4-directed Blocking Antibody [EPC] 1 0.0000
41 Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] 1 0.0000
42 Macrolide Antimicrobial [EPC] 1 0.0000
43 Sodium-Glucose Cotransporter 2 Inhibitor [EPC] 2 0.0000
44 Peroxisome Proliferator Receptor alpha Agonist [EPC] 1 0.0000
45 Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] 2 0.0000
46 Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC] 2 0.0000
47 Histamine-2 Receptor Antagonist [EPC] 2 0.0000
48 Nitroimidazole Antimicrobial [EPC] 1 0.0000
49 Tetracycline-class Drug [EPC] 1 0.0000
50 Xanthine Oxidase Inhibitor [EPC] 2 0.0000
51 Dietary Cholesterol Absorption Inhibitor [EPC] 1 0.0000
52 Estrogen [EPC] 2 0.0000
53 Programmed Death Receptor-1 Blocking Antibody [EPC] 1 0.0000
54 Aminosalicylate [EPC] 1 0.0000
55 5-alpha Reductase Inhibitor [EPC] 1 0.0000
56 Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] 1 0.0000
57 Proton Pump Inhibitor [EPC] 5 0.0000
58 Serotonin-3 Receptor Antagonist [EPC] 1 0.0000
59 Opioid Agonist [EPC] 2 0.0000
60 Angiotensin Converting Enzyme Inhibitor [EPC] 1 0.0000
61 Tumor Necrosis Factor Blocker [EPC] 7 0.0000
62 Platelet Aggregation Inhibitor [EPC] 4 0.0000
63 Osmotic Laxative [EPC] 2 0.0000
64 Vitamin D [EPC] 2 0.0000
65 Vitamin B12 [EPC] 2 0.0000
66 Expectorant [EPC] 1 0.0000
67 Vitamin C [EPC] 2 0.0000
68 Nonsteroidal Anti-inflammatory Drug [EPC] 6 0.0000
69 Insulin Analog [EPC] 2 0.0000
70 Retinoid [EPC] 1 0.0000
71 Platinum-based Drug [EPC] 1 0.0000
72 Factor Xa Inhibitor [EPC] 1 0.0000
73 Dihydropyridine Calcium Channel Blocker [EPC] 1 0.0000
74 Loop Diuretic [EPC] 1 0.0000
75 Interleukin-4 Receptor alpha Antagonist [EPC] 1 0.0000
76 Benzodiazepine [EPC] 1 0.0000